Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2026-01-22 @ 3:36 AM
Study NCT ID:
NCT06747468
Status:
RECRUITING
Last Update Posted:
2025-10-09
First Post:
2024-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Avexitide for Treatment of Post-Bariatric Hypoglycemia
Sponsor:
Amylyx Pharmaceuticals Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Post Bariatric Hypoglycemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | avexitide | View |
| None | post bariatric hypoglycemia | View |
| None | PBH | View |
| None | hypoglycemia | View |
| None | hypoglycemia post bariatric surgery | View |
| None | Roux-en-Y gastric bypass (RYGB) | View |
| None | RYGB | View |
| None | AVX | View |
| None | LUCIDITY | View |
| None | exendin 9-39 | View |
| None | exendin | View |
| None | exendin 939 | View |
| None | Roux-en-Y | View |
| None | gastric bypass | View |
| None | low blood sugar | View |
| None | Roux-en-Y gastric bypass | View |